Home LiteratureArticle Details
PMID: 10371499 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation.

Nature medicine ·Vol. 5 ·No. 6 ·1999-06-00 ·Pages 623-8

Gerber HP, Vu TH, Ryan AM, Kowalski J, Werb Z, Ferrara N

Abstract

Hypertrophic chondrocytes in the epiphyseal growth plate express the angiogenic protein vascular endothelial growth factor (VEGF). To determine the role of VEGF in endochondral bone formation, we inactivated this factor through the systemic administration of a soluble receptor chimeric protein (Flt-(1-3)-IgG) to 24-day-old mice. Blood vessel invasion was almost completely suppressed, concomitant with impaired trabecular bone formation and expansion of hypertrophic chondrocyte zone. Recruitment and/or differentiation of chondroclasts, which express gelatinase B/matrix metalloproteinase-9, and resorption of terminal chondrocytes decreased. Although proliferation, differentiation and maturation of chondrocytes were apparently normal, resorption was inhibited. Cessation of the anti-VEGF treatment was followed by capillary invasion, restoration of bone growth, resorption of the hypertrophic cartilage and normalization of the growth plate architecture. These findings indicate that VEGF-mediated capillary invasion is an essential signal that regulates growth plate morphogenesis and triggers cartilage remodeling. Thus, VEGF is an essential coordinator of chondrocyte death, chondroclast function, extracellular matrix remodeling, angiogenesis and bone formation in the growth plate.

MeSH Terms
Animals Bone and Bones/anatomy & histology,physiology Cartilage/anatomy & histology,physiology Cell Division Chondrocytes/cytology,drug effects,metabolism Endothelial Growth Factors/physiology Immunoglobulin G/genetics,pharmacology Lymphokines/physiology Mice Mice, Inbred C57BL Neovascularization, Physiologic/physiology Osteogenesis/physiology Platelet Endothelial Cell Adhesion Molecule-1/metabolism Proto-Oncogene Proteins/genetics,pharmacology Receptor Protein-Tyrosine Kinases/genetics,metabolism,pharmacology Receptors, Growth Factor/metabolism Receptors, Vascular Endothelial Growth Factor Recombinant Fusion Proteins/genetics,pharmacology Recombinant Proteins/genetics,pharmacology Vascular Endothelial Growth Factor A Vascular Endothelial Growth Factor Receptor-1/genetics,pharmacology Vascular Endothelial Growth Factors
Chemicals
Endothelial Growth Factors Flt(1-3)-IgG Immunoglobulin G Lymphokines Platelet Endothelial Cell Adhesion Molecule-1 Proto-Oncogene Proteins Receptors, Growth Factor Recombinant Fusion Proteins Recombinant Proteins Vascular Endothelial Growth Factor A Vascular Endothelial Growth Factors Receptor Protein-Tyrosine Kinases Receptors, Vascular Endothelial Growth Factor Vascular Endothelial Growth Factor Receptor-1
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Gerber H P
Department of Cardiovascular Research, Genentech, South San Francisco, California 94080, USA.
Vu T H
Ryan A M
Kowalski J
Werb Z
Ferrara N
Article Info
Journal
Nature medicine
Abbr.
Nat Med
ISSN
1078-8956
Published
1999-06-00
Pages
623-8
Language
English
Region
United States
NLM ID
9502015
Subset
IM
Grants
NIDCR NIH HHS · DE10306 · United States
NHLBI NIH HHS · HL03880 · United States
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com